Effectiveness of systemic chemotherapy using CBDCA and 5-FU in a case of hepatocellular carcinoma with metastases to the lung

Kanzo/Acta Hepatologica Japonica

Volumn 52, Issue 1, 2011, Pages 42-49

  Hirano, Genryu ^a,b   Kitamura, Yuji ^a   Shiga, Hiroshi ^a   Ikeda, Kenji ^a   Morita, Isamu ^a   Uno, Hiroyuki ^a   Arita, Yoshiyuki ^a   Umeda, Fumio ^a   Sohda, Tetsuro ^b   Sakisaka, Shotaro ^b  

^a Fukuoka City Medical Association Hospital   (Japan)

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 FU; CBDCA (carboplatin); Hepatocellular carcinoma; Lung metastases; Systemic chemotherapy

Indexed keywords

CARBOPLATIN; FLUOROURACIL;

AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER RECURRENCE; CASE REPORT; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; HUMAN; LIVER CELL CARCINOMA; LUNG METASTASIS; MALE; TREATMENT OUTCOME;

EID: 79951904070     PISSN: 04514203     EISSN: None     Source Type: Journal    
DOI: 10.2957/kanzo.52.42     Document Type: Article

References (17)

1. Poon RT, Fan ST, Tsang FH, et al. Locoregional therapies for hepatocellular carcinoma: a critical review from surgeon's perspective. Ann Surg 2002; 235: 466-486 (Pubitemid 34258345)
2. CLINICIAN 1997 ; 458 : 79-83
3. Nowak AK, Chow PKH, Findlay M. Systemic therapy for advanced hepatocellular carcinoma: a review. Eur J Cancer 2004; 40: 1474-1484 (Pubitemid 38757734)
4. Therasse P, Afbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92: 205-216 (Pubitemid 30099779)
5. Lam CM, Lo CM, Yuen WK, et al. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Sung 1998; 85: 1198-1200
6. Lai CL, Lau JY, Wu PC, et al. Recombinant interferon-alfa in inoperable hepatocelullar carcinoma: a randomized controlled trial. Hepatology 1993; 17: 384-394
7. Llovet JM, Sala M, Castells L, et al. Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma. Hepatology 2000; 31: 54-58 (Pubitemid 30033689)
8. Wadler S, Schwards EL, Oldman M, et al. Fluorouracil and recombinant alfa-2 a-interferon: an active regimen against advanced colorectal carcinoma. J Clin Oncol 1989; 7: 1769-1775 (Pubitemid 20014322)
9. Chung YH, Song IH, Song BC, et al. Combination chemotherapy consisting of intra-arterial cisplatin infusion and systemic interferon alfa for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 2000; 88: 1986-1991
10. Llovet JM, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390